银杏酮酯分散片治疗脑小血管病所致轻度认知障碍的疗效观察被引量：12

在线阅读下载PDF

导出

摘要目的探讨银杏酮酯分散片治疗脑小血管病所致轻度认知障碍的临床疗效。方法将86例脑小血管病所致轻度认知障碍患者随机分成两组,治疗组给予银杏酮酯分散片(0.45 g/d),对照组给予多奈哌齐(5 mg/d),疗程6个月。观察两组治疗前后简易智能状态量表(MMSE)以及日常生活活动能力评定量表(ADL)评分变化。结果治疗后,两组MMSE评分较治疗前均有所提高,ADL评分较治疗前降低,差异有统计学意义(P<0.01)。两组治疗后比较差异无统计学意义(P>0.05)。结论银杏酮酯分散片能显著改善SVD所致轻度认知障碍患者MMSE、ADL评分,且评分改善程度与多奈哌齐相当。

作者张骐陈爱霞陈燕刘为民

机构地区江苏省南通市瑞慈医院

出处《中西医结合心脑血管病杂志》 2014年第10期1231-1232,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

关键词脑小血管病轻度认知障碍银杏酮酯分散片

分类号 R277.7 [医药卫生—中医学]

引文网络
相关文献

参考文献9

1詹羽,刘煜敏.脑小血管病[J].卒中与神经疾病,2014,21(1):59-61. 被引量：6
2贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量：266
3董博,张志珺.轻度认知障碍筛查量表研究进展[J].中华脑血管病杂志（电子版）,2011,5(4):31-34. 被引量：8
4Ferrer I.Cognitive impairment of vascular origin:Neuropathologyof cognitive impairment of vascular origin[J].J Neurol Sci,2010,299(1/2):139 -149.
5Xu YP,Yao TW,Jiang JW.HPLC fingerprint of the tablets ofGinkgo biloba[J].Journal of Zhejiang University (Medical Sci- ences),2004,33:24 -27.
6张兰英,王玉良.银杏叶提取物对拟血管性痴呆大鼠海马CA1区的保护作用[J].神经解剖学杂志,2007,23(3):309-312. 被引量：11
7Lin CC,Cheng WL,Hsu SH,et al .The effects of Ginkgo bilobaextracts on the memory and motor functions of rats with chroniccerebral insufficiency[J].Neuropsychobiology,2003,47(1):47-51.
8Shen J,Lee W,Gu Y,et al .Ginkgo biloba extract(EGb761)in- hibits mitochondria dependent caspase pathway and preventsapoptosis in hypoxia reoxygenated cardiomyocytes [J].ChinMed,2011,6:8.
9Kaufman AM,Milnerwood AJ,Sepers MD,et al .Opposing rolesof synaptic and extrasynaptic NMDA receptor signaling in cocu- hured striatal and cortical neurons[J].J Neurosci,2012,32:3992-4003.

二级参考文献67

1王姮,张新卿,汤哲,周景升,孙厚亮.老年人认知功能减退知情者问卷检测老年人认知功能损害[J].中华老年医学杂志,2006,25(5):386-388. 被引量：19
2Scanlan JM, Brush M, Quijano C, et al. Comparing clock tests for dementia screening: naive judgments vs formal systems--what is optimal? Int J Geriatr Psychiatry,2002,17 ( 1 ) : 14-21.
3Jarvenpaa T, Rinne JO, Raiha I, et al. Characteristics of two telephone screens for cognitive impairment. Dement Geriatr Cogn Disord,2002, 13(3) : 149-155.
4Serby, M, Mohan C, Aryan M, et al. Olfactory identification deficits in relatives of Alzheimer' s disease patients. Biol Psychiatry, 1996,39 (5) : 375-377.
5Pearson RC. Cortical connections and the pathology of Alzheimer' s disease. Neurodegeneration, 1996,5 (4) : 429-434.
6Wilson, RS, Schneider JA, Arnold SE, et al. Olfactory identification and incidence of mildcognitive impairment in older age. Arch Gen Psychiatry,2007,64(7 ) : 802-808.
7Nasreddine, ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA : a brief screening tool for mild cognitive impairment. J Am Geriatr Soc,2005,53(4) : 695-699.
8Kalbe E, Kessler J, Calabrese P, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry, 2004,19 (2) : 136-143.
9Tang-Wai, DF, Knopman DS, Geda YE, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol,2003,60(12) : 1777-1781.
10Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE) : a review. Int Psychogeriatr,2004,16 ( 3 ) : 275- 293.